PHLDA2 and osteosarcoma: Gain-and-loss or loss-and-gain functional approaches confirmed that RanBP9 and TSSC3 functioned cooperatively, likely as a protein complex, to modify anoikis resistance, anchorage-independent growth, and more importantly, the metastatic ability of osteosarcoma cells.